GENETIC PROFILING OF MALIGNANT MESOTHELIOMA IN PLEURAL EFFUSIONS SHOWS HIGH VARIABILITY

被引：0
|
作者：
Sneddon, S. [1 ]
Brown, S. [2 ,3 ]
Holt, R. [2 ]
Robinson, B. [1 ]
Creaney, J. [1 ]
机构：
[1] Univ Western Australia, Natl Ctr Asbestos Related Dis, Sch Med & Pharmacol, Nedlands, WA 6009, Australia
[2] BC Canc Agcy, Michael Smith Genome Sci Ctr, Surrey, BC, Canada
[3] Univ British Columbia, Genome Sci Technol Grad Program, Vancouver, BC V5Z 1M9, Canada
来源：
RESPIROLOGY | 2016年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
TO 055
引用
收藏
页码：48 / 48
页数：1
相关论文
共 50 条
  • [31] MALIGNANT PLEURAL EFFUSIONS
    FRIEDMAN, MA
    SLATER, E
    CANCER TREATMENT REVIEWS, 1978, 5 (02) : 49 - 66
  • [32] Precision immunotherapy; dynamics in the cellular profile of pleural effusions in malignant mesothelioma patients
    Lievense, Lysanne A.
    Bezemer, Koen
    Cornelissen, Robin
    Kaijen-Lambers, Margaretha E. H.
    Hegmans, Joost P. J. J.
    Aerts, Joachim G. J. V.
    LUNG CANCER, 2017, 107 : 36 - 40
  • [33] T cell phenotype and receptor expression in pleural effusions associated with malignant mesothelioma
    McDonnell, A.
    Chee, J.
    Nowak, A.
    Robinson, B.
    Lake, R.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 207 - 208
  • [34] Regulatory T cells and cytokines in malignant pleural effusions secondary to mesothelioma and carcinoma
    DeLong, P
    Carroll, RG
    Henry, AC
    Tanaka, T
    Ahmad, S
    Leibowitz, MS
    Sterman, DH
    June, CH
    Albelda, SM
    Vonderheide, RH
    CANCER BIOLOGY & THERAPY, 2005, 4 (03) : 342 - 346
  • [35] Personalized circulating tumor DNA profiling in malignant pleural mesothelioma
    Martinson, Luke J.
    Sharkey, Annabel J.
    Dawson, Alan G.
    Hastings, Robert K.
    Wilson, Gareth
    Waller, David
    Nakas, Apostolos
    Swanton, Charles
    Shaw, Jacqui A.
    Fennell, Dean A.
    CANCER RESEARCH, 2019, 79 (13)
  • [36] IS THERE A GENETIC MODEL IN THE GENESIS OF MALIGNANT PLEURAL MESOTHELIOMA - REPLY
    HAMMAR, SP
    HUMAN PATHOLOGY, 1990, 21 (09) : 983 - 983
  • [37] Asbestos exposure and genetic susceptibility to malignant pleural mesothelioma
    Karageorgi, S.
    Christensen, B. C.
    McClean, M. D.
    Roelofs, C. R.
    Sugarbaker, D. J.
    Byler, S.
    Kelsey, K. T.
    Nelson, H. H.
    LUNG CANCER, 2006, 54 : S36 - S37
  • [38] Pleural malignant mesothelioma, genetic susceptibility and asbestos exposure
    Neri, M
    Filiberti, R
    Taioli, E
    Garte, S
    Paracchini, V
    Bolognesi, C
    Canessa, PA
    Fontana, V
    Ivaldi, GP
    Verna, A
    Bonassi, S
    Puntoni, R
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2005, 592 (1-2) : 36 - 44
  • [39] Utility of hyaluronic acid in pleural fluid for differential diagnosis of pleural effusions: Likelihood ratios for malignant mesothelioma
    Atagi, S
    Ogawara, M
    Kawahara, M
    Sakatani, M
    Furuse, K
    Ueda, E
    Yamamoto, S
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1997, 27 (05) : 293 - 297
  • [40] Value of plasma and pleural effusion fibulin-3 levels in the diagnosis of malignant pleural mesothelioma effusions
    Elgazzar, Alaa Eldin M.
    Embarak, Sameh
    Refat, Ali M.
    Bakry, Ahmed
    Mokhtar, Ahmed
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2014, 63 (04): : 891 - 896
12345